Pediatric COVID-19 Vaccine Clinical Study
Clinical Research Associates and Meharry Medical College are studying COVID vaccines in children aged 6 months to 11 years old. Clinical Research Associates is no longer enrolling new patients into this study. However, to enroll in Meharry’s study, click here.
If you are the parent or caregiver of a child enrolled in CRA’s Pediatric COVID-19 vaccine, click here for an important update about the FDA’s decision on emergency use authorization.
About the Study:
Protecting the health and human rights of a clinical study participant are the most important aspects of any study, especially those involving youth.
Participating in a clinical trial is an important and personal decision. That’s especially true when considering a study for a child. CRA and MMC are committed to improving the health and well-being of children through thoughtfully designed and carefully administered clinical trials.
The participants in these clinical studies help to improve the health of children around the world. Some pediatric clinical studies are designed to develop pediatric prescribing information for medicines already being used in adults. Others are specific to diseases that uniquely or especially impact the lives of children, such as those that prevent disease—like vaccines—or are related to genetic conditions. What all studies have in common is a dedication to the protection of human rights and advancement of life-saving medicine.
Still have questions? We understand. Read our FAQ section here, or call us to talk to a real person at (615) 329-2222.